Post-effective amendment to a registration statement that is not immediately effective upon filing

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.21.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:        
Net loss $ (59,108) $ (21,804) $ (34,015) $ (103,596)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 3,892 2,321 8,589 8,087
Stock-based compensation 2,217 1,259 8,006 5,215
Change in fair value of warrant liability 56,576   (56,417)  
Expense related to Common Stock warrants issued   124 1,915 1,038
Loss (gain) on disposal of property and equipment     18 (7)
Gain on investment, related to Make Composites, Inc. (1) 159   (1,426)
Impairment of capitalized software       444
Amortization (accretion) of discount on investments 406 (22) 75 (1,570)
Amortization of debt financing cost 4 4 19 19
Provision for bad debt 72   377 199
Net increase in accrued interest related to marketable securities (240) (124) (3) (36)
Deferred tax benefit (27,921)   (940)  
Changes in operating assets and liabilities:        
Accounts receivable (61) 752 (2,370) (1,664)
Inventory (2,381) (3,238) (1,303) (1,694)
Prepaid expenses and other current assets (4,276) 393 901 809
Accounts payable (3,856) (989) (2,637) (4,455)
Accrued expenses and other current liabilities (5,247) (976) (2,391) 3,272
Customer deposits (1,234) 285 (845) 152
Deferred revenue 105 (339) 774 (1,693)
Change in right of use assets and lease liabilities, net (22) (80) (328) (296)
Net cash used in operating activities (41,129) (22,434) (80,575) (97,202)
Cash flows from investing activities:        
Purchases of property and equipment (262) (1,004) (1,429) (6,867)
Purchase of other investments     (3,000)  
Capitalized software       (321)
Purchase of marketable securities (92,386) (17,616) (136,286) (215,584)
Proceeds from sales and maturities of marketable securities 48,241 49,300 109,016 196,836
Cash paid for asset acquisition, net of cash acquired (137,646)   (5,284) (96)
Net cash (used in) provided by investing activities (182,053) 30,680 (36,983) (26,032)
Cash flows from financing activities:        
Proceeds from Preferred Stock issuances, net of issuance cost       159,644
Proceeds from reverse recapitalization, net of issuance costs     534,597  
Proceeds from exercise of stock options 180 132 325 708
Proceeds from PPP loan     5,379  
Repayment of PPP loan     (5,379)  
Net cash provided by financing activities 157,195 132 534,922 160,352
Net (decrease) increase in cash, cash equivalents, and restricted cash (65,987) 8,378 417,364 37,118
Cash and cash equivalents at beginning of period 483,525 66,161 66,161 29,043
Restricted cash   612 612 612
Cash, cash equivalents, and restricted cash at end of period 418,176 75,151 484,137 66,773
Supplemental cash flow information:        
Interest paid 73 $ 107 322 485
Non-cash investing and financing activities:        
Net liabilities assumed from Trine in Business Combination     152,395  
Accrued reverse recapitalization transaction costs     1,901  
Common Stock issued for acquisitions 159,847   500 3,563
Accrued purchase price for asset acquisition     200  
Tax liabilities related to withholdings on Common Stock issued in connection with acquisitions     $ 102  
Additions to right of use assets and lease liabilities 364     296
Purchase of property and equipment included in accrued expenses and other current liabilities $ 50     109
Common Stock forfeited in satisfaction of note receivable       $ 249